UPK3A | Uroplakin 3A | Disease related genes Predicted membrane proteins
| | | | | Group enriched |
AL162431.1 | Uncharacterized protein | | | | | | Group enriched |
CECR6 | Cat eye syndrome chromosome region, candidate 6 | Predicted membrane proteins
| | | | | Group enriched |
HOXD13 | Homeobox D13 | Cancer-related genes Disease related genes Transcription factors
| | | | | Group enriched |
NCAPD3 | Non-SMC condensin II complex, subunit D3 | Plasma proteins
| | | | | Tissue enriched |
POTEM | POTE ankyrin domain family, member M | Predicted membrane proteins
| | | | | Tissue enriched |
RBFOX3 | RNA binding protein, fox-1 homolog (C. elegans) 3 | | | | | | Group enriched |
SLC39A2 | Solute carrier family 39 (zinc transporter), member 2 | Predicted membrane proteins
| | | | | Group enriched |
SORD | Sorbitol dehydrogenase | Enzymes Plasma proteins
| | | | | Group enriched |
ACOXL | Acyl-CoA oxidase-like | | | | | | Group enriched |
ARG2 | Arginase 2 | Cancer-related genes Enzymes Mitochondrial proteins
| | | | | Group enriched |
CLVS2 | Clavesin 2 | | | | | | Group enriched |
CNTNAP2 | Contactin associated protein-like 2 | Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | | | | Group enriched |
DLX1 | Distal-less homeobox 1 | Transcription factors
| | | | | Group enriched |
KCNJ3 | Potassium inwardly-rectifying channel, subfamily J, member 3 | Plasma proteins Predicted membrane proteins Transporters Voltage-gated ion channels
| | | | | Group enriched |
NTNG2 | Netrin G2 | Predicted secreted proteins
| | | | | Group enriched |
NWD1 | NACHT and WD repeat domain containing 1 | | | | | | Group enriched |
POTEG | POTE ankyrin domain family, member G | Predicted membrane proteins
| | | | | Tissue enriched |
RDH11 | Retinol dehydrogenase 11 (all-trans/9-cis/11-cis) | Enzymes Predicted secreted proteins
| | | | | Tissue enriched |
TBL1Y | Transducin (beta)-like 1, Y-linked | | | | | | Tissue enriched |
TTC6 | Tetratricopeptide repeat domain 6 | | | | | | Group enriched |
ABCC4 | ATP-binding cassette, sub-family C (CFTR/MRP), member 4 | Plasma proteins Predicted membrane proteins Transporters
| | | | | Tissue enhanced |
ACSM1 | Acyl-CoA synthetase medium-chain family member 1 | Enzymes Mitochondrial proteins Predicted membrane proteins
| | | | | Tissue enhanced |
ADRA1D | Adrenoceptor alpha 1D | FDA approved drug targets G-protein coupled receptors Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
AGBL1 | ATP/GTP binding protein-like 1 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ALDH1A3 | Aldehyde dehydrogenase 1 family, member A3 | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |
ALOX15B | Arachidonate 15-lipoxygenase, type B | Cytoskeleton related proteins Enzymes
| | | | | Tissue enhanced |
ALX4 | ALX homeobox 4 | Disease related genes Transcription factors
| | | | | Tissue enhanced |
ANO7 | Anoctamin 7 | Predicted membrane proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGAP6 | Rho GTPase activating protein 6 | Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
ARHGEF38 | Rho guanine nucleotide exchange factor (GEF) 38 | | | | | | Tissue enhanced |
ASTN2 | Astrotactin 2 | Predicted membrane proteins
| | | | | Tissue enhanced |
AZGP1 | Alpha-2-glycoprotein 1, zinc-binding | Cancer-related genes Plasma proteins Predicted secreted proteins
| | | | | Tissue enhanced |
BMPR1B | Bone morphogenetic protein receptor, type IB | CD markers Disease related genes Enzymes Potential drug targets Predicted membrane proteins
| | | | | Tissue enhanced |
C7orf63 | Chromosome 7 open reading frame 63 | | | | | | Tissue enhanced |
C9orf92 | Chromosome 9 open reading frame 92 | Predicted membrane proteins
| | | | | Tissue enhanced |
CCDC183 | Coiled-coil domain containing 183 | | | | | | Tissue enhanced |
CDH26 | Cadherin 26 | Plasma proteins Predicted membrane proteins
| | | | | Tissue enhanced |
CLUL1 | Clusterin-like 1 (retinal) | Predicted secreted proteins
| | | | | Tissue enhanced |
COL13A1 | Collagen, type XIII, alpha 1 | Predicted membrane proteins
| | | | | Tissue enhanced |
COL2A1 | Collagen, type II, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
COL9A1 | Collagen, type IX, alpha 1 | Disease related genes Predicted secreted proteins
| | | | | Tissue enhanced |
CPA6 | Carboxypeptidase A6 | Disease related genes Enzymes Potential drug targets Predicted secreted proteins
| | | | | Tissue enhanced |
CPLX3 | Complexin 3 | | | | | | Tissue enhanced |
CPNE4 | Copine IV | | | | | | Tissue enhanced |
CRISPLD1 | Cysteine-rich secretory protein LCCL domain containing 1 | Plasma proteins
| | | | | Tissue enhanced |
CWH43 | Cell wall biogenesis 43 C-terminal homolog (S. cerevisiae) | Predicted membrane proteins
| | | | | Tissue enhanced |
EVX1 | Even-skipped homeobox 1 | Transcription factors
| | | | | Tissue enhanced |
EVX2 | Even-skipped homeobox 2 | Transcription factors
| | | | | Tissue enhanced |
EYA1 | Eyes absent homolog 1 (Drosophila) | Disease related genes Enzymes Potential drug targets
| | | | | Tissue enhanced |